References
Choi J Y, Kwon O K, Choi S Y, et al. 2010. Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay. J Clin Virol, [Oct 20. Epub ahead of print]
Geng Q M, Li H P, Bao Z Y, et al. 2010. Indinavir resistance evolution in one human immunodeficiency virus type 1 infected patient revealed by single-genome amplification. Virol Sin, 25(5): 316–328.
Pushkarev D, Neff N F, Quake S R. 2009. Single-molecule sequencing of an individual human genome. Nat Biotechnol, 27(9): 847–852.
Rhee S Y, Taylor J, Fessel W J, et al. 2010. HIV-1 protease mutations and protease inhibitor cross-resistance. Animicrob Agents Chemother, 54(10): 4253–4261.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wiwanitkit, V. Indinavir resistance evolution: a comment. Virol. Sin. 26, 72 (2011). https://doi.org/10.1007/s12250-011-3173-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12250-011-3173-6
Keywords
- Human Immunodeficiency Virus Type
- Indinavir
- Transcriptase Inhibitor
- Drug Susceptibility
- Resistance Evolution